| Serial Number | 79408132 |
| Word Mark | CELLTOLERANCE |
| Filing Date | Monday, July 22, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, March 16, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 7, 2026 |
| Pseudo Mark | CELL TOLERANCE |
| Goods and Services | Health care services for human beings, namely gastrointestinal health care services; medical analysis services relating to the treatment of patients; medical services for the remote analysis of optical samples and diagnosis on cells; medical services relating to the collection, treatment and processing of human cells; medical assessment of health status for medical diagnostic purposes; medical diagnosis services, namely, medical diagnosis of digestive disorders; medical diagnostic and testing services in relation to digestive and gastrointestinal diseases and disorders; medical testing services for diagnostic or treatment purposes; health care management in the nature of developing care protocols in relation to digestive and gastrointestinal diseases and disorders; providing news and information in the field of medicine; provision of information relating to medical services; provision of medical information in the field of health; providing medical information in the field of gastroenterology; individual medical advisory services provided to patients; medical testing services for the diagnosis and treatment of persons |
| Goods and Services | Scientific and technological services, namely, scientific research and design services in the field of diagnostic tools for medical applications; Development of new technology on behalf of third parties in the field of biotechnology; providing information relating to medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; scientific research and development in the field of pharmaceuticals and biotechnology; analyzing, assessing and reporting diagnostic test results and diagnostic or prognostic tests of residual disease to assist healthcare professionals in the clinical diagnosis of a patient, to assess the effectiveness of treatments prescribed to patients and change future treatments accordingly; medical and scientific research in the field of treatment and diagnosis of digestive and gastrointestinal diseases and disorders |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MAUNA KEA TECHNOLOGIES |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | FR |
| Event Date | Event Description |
| Thursday, October 31, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 1, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 8, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, January 15, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, January 16, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, March 4, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 4, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, March 22, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, August 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 20, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 22, 2025 | FINAL REFUSAL WRITTEN |
| Friday, August 22, 2025 | FINAL REFUSAL E-MAILED |
| Friday, August 22, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, March 11, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 11, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 11, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 11, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 11, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 18, 2026 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, March 18, 2026 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Sunday, March 29, 2026 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, March 30, 2026 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |